EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY 4.0

Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization

Lin Chen, Yanlun Gu, Yuke Chen, Wei Yu, Ying Zhou, Zhuona Rong iD, Xiaocong Pang iD

eLife · 2025

DOI: 10.7554/elife.101584 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift eLife, 2025. Verfasst von Lin Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Mendelian Randomization Analysis, Blood Proteins, Proteome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Natural Science Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) diagnosis is hampered by the limited specificity of current methods, necessitating more reliable biomarkers. To identify causal protein biomarkers and therapeutic targets in humans, we conducted a proteome-wide Mendelian randomization (MR) study. We first performed a meta-analysis of two independent genome-wide association studies, including 94,397 individuals with PCa and 192,372 controls, which identified five possible susceptibility loci (JAZF1, PDILM5, WDPCP, EEFSEC, TNS3) for PCa. Subsequently, MR and colocalization analyses were performed using genetic instruments for 4907 plasma proteins from deCODE Genetics (N=35,559) and 2940 plasma proteins from UK Biobank Pharma Proteomics Project (UKB-PPP) (N=54,219). Among 3722 human proteins analyzed, 193 were associated with PCa risk, with 20 high-risk proteins (including KLK3) validated across both cohorts. Functional annotation implicated immune and inflammatory responses and cell–cell interaction pathways. Druggability analyses nominated several potential drug targets for PCa, such as HSPB1, RRM2B, and PSCA. Our findings reveal novel risk loci and candidate protein biomarkers, providing new etiological insights and potential avenues for PCa early detection and therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMendelian Randomization AnalysisBlood ProteinsProteomeBiomarkers, TumorHumansMaleGenome-Wide Association StudyGenetic Predisposition to Disease

Stichwörter der Autor:innen

Mendelian randomizationbiomarkerscancer biologycolocalization analysishumanprostate cancerproteins

Substanzen

Blood ProteinsProteomeBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pharmacy, Peking University First Hospital, Beijing, China.
  • School of Pharmaceutical Sciences, Peking University, Beijing, China.
  • Department of Urology, Peking University First Hospital, Beijing, China.

ORCID-Profile: Zhuona Rong, Xiaocong Pang

Förderung

  • Beijing Municipal Natural Science Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Chen, L., Gu, Y., Chen, Y., Yu, W., Zhou, Y., Rong, Z., & Pang, X. (2025). Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization. eLife. https://doi.org/10.7554/elife.101584

Vancouver

Chen L, Gu Y, Chen Y, Yu W, Zhou Y, Rong Z, et al. Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization. eLife. 2025. doi:10.7554/elife.101584

BibTeX
@article{Chen2025,
  author = {Chen, Lin and Gu, Yanlun and Chen, Yuke and Yu, Wei and Zhou, Ying and Rong, Zhuona and Pang, Xiaocong},
  title = {Causal associations between human plasma proteins and prostate cancer identified by proteome-wide Mendelian randomization},
  journal = {eLife},
  year = {2025},
  doi = {10.7554/elife.101584}
}
Kostenlos starten →